CAYSTON: Vials may be cracked in affected lots
Last updated
Summary
Product
CAYSTON
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
CAYSTON |
CAYSTON |
DIN 02329840 |
Powder For Solution |
Aztreonam 75 mg |
032168, |
Issue
Vials may be cracked in affected lots.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers, Retailers, End Users
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Gilead Sciences Canada Inc.
6711 Mississauga Rd., Suite 600
Mississauga, ON L5N 2W3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-73094
Get notified
Receive notifications for new and updated recalls and alerts by category.